FOXO unit Vector BioSource agrees to buy four Grifols blood collection centers for $3.5 million plus up to $1 million earnout
FOXO TECHNOLOGIES INC. CEO SEAMUS LAGAN PROVIDES MID-YEAR UPDATE TO SHAREHOLDERS | FOXO Stock News
FOXO TECHNOLOGIES, INC., FORMS STRATEGIC PARTNERSHIP WITH LONGEVITYFP TECHNOLOGIES, LLC. TO COMMERCIALIZE FOXO’S EPIGENETICS TECHNOLOGY | FOXO Stock News
FOXO Tech | 10-Q: FY2026 Q1 Revenue: USD 5.168 M
FOXO Technologies Expands Authorized Class A Share Capacity
FOXO Technologies Signs Series E Preferred Stock Exchange Agreement With Rennova Health